2 Dead In Class I Recall Of Medtronic Stents

The medtech giant yanked from shelves in July its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology. The recall was labeled high-risk class I by the US FDA on 20 September. It’s the company’s ninth class I this year.

Sign of Medtronic at Canada Headquarters in Brampton, Ontario, Canada.

More from Recalls

More from Policy & Regulation